Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies.
نویسندگان
چکیده
Dementia with Lewy bodies (DLB) is one of the most common neurodegenerative diseases and shares multiple clinical and neuropathological parallels with Alzheimer's (AD) and Parkinson's disease (PD). A variety of clinical signs are suggestive for the diagnosis, and imaging (βCIT SPECT) contributes substantially to the diagnosis. The study reported here was performed in search for a biomarker in the cerebrospinal fluid (CSF) of these patients. We applied 2D fluorescence difference gel electrophoresis and mass spectrometry to analyze the CSF proteome pattern of DLB patients after depleting twelve high-abundant proteins. The densitometric analysis of 2D gels showed the up- or down-regulation of 44 protein spots. Subsequently, 23 different proteins were identified. The majority is involved in acute phase and immune response. Many of these proteins were previously reported before as being associated with AD or PD, which strongly suggests a molecular cross-talk and may explain clinical and pathological overlap of these disease entities. Among the identified proteins are two highly upregulated proteins-inter alpha trypsin inhibitor heavy chain (ITIH4) and calsyntenin 1-that may have the potential to serve as molecular biomarkers specific for DLB. The identification of DLB-associated proteome changes will help to further understand pathological processes occurring in DLB and may provide future prospects to diagnostic and therapeutic options.
منابع مشابه
Age-related Cognitive Dysfunction (Dementia): A Natural Approach
TABLE 1 – DEMENTIA: TYPE, CAUSES & TREATMENTS Type Cause Conventional Treatment Dementia of Alzheimer type (DAT) Plaques, tangles, transmitter defects, abnormal amyloid deposition Anticholinesterases, nerve growth Factor Vascular dementia Multiple infarcts, stroke, small vessel disease Aspirin, lower blood pressure, lower cholesterol Lewy body dementia Lewy bodies, transmitter defects Anticholi...
متن کاملOp-brai150350 1..14
Extracellular a-synuclein has been proposed as a crucial mechanism for induction of pathological aggregate formation in previously healthy cells. In vitro, extracellular a-synuclein is partially associated with exosomal vesicles. Recently, we have provided evidence that exosomal a-synuclein is present in the central nervous system in vivo. We hypothesized that exosomal a-synuclein species from ...
متن کاملInduction of a-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
Extracellular a-synuclein has been proposed as a crucial mechanism for induction of pathological aggregate formation in previously healthy cells. In vitro, extracellular a-synuclein is partially associated with exosomal vesicles. Recently, we have provided evidence that exosomal a-synuclein is present in the central nervous system in vivo. We hypothesized that exosomal a-synuclein species from ...
متن کاملInduction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
Extracellular α-synuclein has been proposed as a crucial mechanism for induction of pathological aggregate formation in previously healthy cells. In vitro, extracellular α-synuclein is partially associated with exosomal vesicles. Recently, we have provided evidence that exosomal α-synuclein is present in the central nervous system in vivo. We hypothesized that exosomal α-synuclein species from ...
متن کاملCerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
More than 750,000 of the UK population suffer from some form of cognitive impairment and dementia. Of these, 5-20% will have Dementia with Lewy Bodies (DLB). Clinico-pathological studies have shown that it is the low frequency of DLB clinical core features that makes the DLB diagnosis hardly recognisable during life, and easily misdiagnosed for other forms of dementia. This has an impact on the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of Alzheimer's disease : JAD
دوره 34 2 شماره
صفحات -
تاریخ انتشار 2013